The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Febuxostat Tillomed 120 mg film-coated tablets

Laboratorios Tillomed Spain, S.L.U.PA2321/004/002

Main Information

Trade NameFebuxostat Tillomed 120 mg film-coated tablets
Active SubstancesFebuxostat
Dosage FormFilm-coated tablet
Licence HolderLaboratorios Tillomed Spain, S.L.U.
Licence NumberPA2321/004/002

Group Information

ATC CodeM04AA03 febuxostat


License statusAuthorised
Licence Issued26/06/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back